{"title":"Peningkatan Kepatuhan Minum Obat Pasien Lupus Eritematosus Sistemik","authors":"Heppy Roosarina Rahayu Dewi, DetyMulyanti","doi":"10.59581/diagnosa-widyakarya.v1i2.210","DOIUrl":null,"url":null,"abstract":"Systemic Lupus Erythematosus (SLE) is an important systemic autoimmune disease. Women are ten times more at risk of developing LES than men. The etiology of SLE is not fully understood and the pathophysiology involves genetic, immunological, endocrine and environmental factors. SLE is a chronic disease with periods of remission and relapse, so it requires different management and a long time. Medication adherence is required so that treatment goals can be achieved. Medication adherence rates in people with lupus have been reported from various studies to be 31.7-45.9%. Non-adherence to treatment for SLE causes an increase in visits to the emergency department and also hospitalization. There are two kinds of factors that influence medication adherence, intentional non-adherence and non-intentional non-adherence. Efforts are needed to improve and increase medication adherence by considering these both factors.","PeriodicalId":204202,"journal":{"name":"DIAGNOSA: Jurnal Ilmu Kesehatan dan Keperawatan","volume":"47 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"DIAGNOSA: Jurnal Ilmu Kesehatan dan Keperawatan","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59581/diagnosa-widyakarya.v1i2.210","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Systemic Lupus Erythematosus (SLE) is an important systemic autoimmune disease. Women are ten times more at risk of developing LES than men. The etiology of SLE is not fully understood and the pathophysiology involves genetic, immunological, endocrine and environmental factors. SLE is a chronic disease with periods of remission and relapse, so it requires different management and a long time. Medication adherence is required so that treatment goals can be achieved. Medication adherence rates in people with lupus have been reported from various studies to be 31.7-45.9%. Non-adherence to treatment for SLE causes an increase in visits to the emergency department and also hospitalization. There are two kinds of factors that influence medication adherence, intentional non-adherence and non-intentional non-adherence. Efforts are needed to improve and increase medication adherence by considering these both factors.